An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer

Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

NCT06751914 ·Status: RECRUITING ·Phase: NA

Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer

NCT01871363 ·Status: UNKNOWN ·Phase: PHASE2

Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients

NCT01554059 ·Status: COMPLETED ·Phase: PHASE2

Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer

NCT06849362 ·Status: ENROLLING_BY_INVITATION

Maintenance Chemotherapy for Metastatic Colorectal Carcinoma and Biological Marker

NCT02043821 ·Status: UNKNOWN ·Phase: NA

The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer

NCT02487992 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

TAS-102 Combined With Bevacizumab for Second-line Maintenance Treatment of Advanced Colorectal Cancer

NCT06293014 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy

NCT05111860 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases

NCT05588297 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer

NCT06584318 ·Status: RECRUITING ·Phase: NA

Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases

NCT05353582 ·Status: UNKNOWN ·Phase: PHASE2

FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type

NCT02350530 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer

NCT05364489 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer

NCT02176746 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC

NCT02893540 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer

NCT07134218 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer

NCT06293612 ·Status: COMPLETED

Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer

NCT05871762 ·Status: RECRUITING

Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

NCT06751966 ·Status: RECRUITING ·Phase: NA

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)

NCT05239741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM

NCT03686254 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Chronic Inflammation, Plasma Proteins Signature, Survival Outcomes and Clinical Response, in Patients Receiving Bevacizumab Combined With Oxaliplatin-based Chemotherapy (Bev/OX) or Bevacizumab Combined With Irinotecan-based Chemotherapy (Bev/IRI)

NCT07241403 ·Status: COMPLETED

Stereotactic Body Radiotherapy for Oligometastases From Colorectal Cancer

NCT02909114 ·Status: UNKNOWN ·Phase: PHASE2

Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer

NCT07059949 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Microwave Ablation for Pulmonary Metastases From Colorectal Cancer

NCT02502630 ·Status: COMPLETED ·Phase: NA